InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (9 ops.)
Insider track record
CFODisclosed buys
1
Disclosed sells
9
T+90 hit rate
0%
T+90 mean return
-13.4%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Levy Adam Scott, Chief Financial Officer. Director active across 1 company, notably Mineralys Therapeutics, Inc.. In total, 12 filings have been logged. Split: 1 buy · 9 sells. Total volume traded: €2.6m. Activity tracked since 14 February 2023. The latest transaction was disclosed on 19 February 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Levy Adam Scott
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations12 total
39,900 shares0Common StockSEC:0001933414-26-000037:0
10,758 shares@ US$32.13640.013% mcap20.6% of flowCommon StockSEC:0001693134-26-000002:0
20,547 shares@ US$10.206.6% of flowCommon StockSEC:0001933414-25-000152:0
7,366 shares@ US$41.90210.012% mcap18.5% of flowCommon StockSEC:0001933414-25-000130:0
12,946 shares@ US$14.04320.0069% mcap10.9% of flowCommon StockSEC:0001933414-25-000081:0
10,758 shares@ US$14.45015.1% of flowCommon StockSEC:0001933414-25-000077:0
10,757 shares@ US$12.05583.6% of flowCommon StockSEC:0001933414-25-000046:0
10,657 shares@ US$9.09273.0% of flowCommon StockSEC:0001933414-25-000005:0
10,757 shares@ US$13.57294.2% of flowCommon StockSEC:0001933414-24-000047:0
10,757 shares@ US$13.14444.1% of flowCommon StockSEC:0001933414-24-000034:0
96,815 shares@ US$12.939336.7% of flowCommon StockSEC:0001933414-24-000027:0
6,250 shares@ US$16.002.9% of flowCommon StockSEC:0001628280-23-003924:0
Canonical exit: 15 May 2023 (T+90)
12 of 12 declarations
About Levy Adam Scott
Adam Scott Levy is the Chief Financial Officer and Secretary of Mineralys Therapeutics, Inc. He is responsible for the company's financial management, including budgeting and financial reporting. His role is crucial in ensuring financial transparency and supporting Mineralys's growth strategy.
